The Japanese National Cancer Research Institute is using Progenesis SameSpots from Nonlinear Dynamics to identify biomarker candidates that could predict the efficacy of chemotherapy for patients of lung cancer.
Dr Kondo, who is leading the group, said: ‘We will be able to select the patients who are destined to have recurrence and improve their clinical outcome by adjuvant chemotherapy.’
The software helps the analysis of 2D single stain and DIGE images for proteomics research. It aligns the images to provide a streamlined, faster 2D workflow by eliminating the need for post-analysis editing. This significantly speeds up the 2D analysis process and reduces the subjectivity of user-operated editing. The SameSpots approach also provides increased statistical power, which generates reliable results that can be used with confidence
